Drawing for PRECAPHARM

USPTO serial 79161248

PRECAPHARM

Reviewed by CopyMark Law Group

Reg. 4938877Status 404
Filing date
Status date
Registration date
Apr 19, 2016
Examiner
CASSIDY, COLLEEN MULCRONE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRECAPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Blake E. Vande Garde

Blake E. Vande Garde Erickson Kernell Derusseau & Kleypas, LLC8900 State Line Road, #500Leawood, KS 66206UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industrySECTION 71 - CANCELLED—
005Pharmaceutical preparations comprising calcium carbonate; pharmaceutical preparations, namely, nutritional supplements for general health and well-being; pharmaceutical anti-allergic preparations; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of Alzheimer's, Huntington's Disease, cerebral palsy, Parkinson's disease, encephalitis, epilepsy, schizophrenia; pharmaceutical preparations for the treatment of cancer, respiratory infections, mood disorders, anxiety disorders, cognitive disorders, autoimmune diseases, dermatitis, cardiovascular diseases; pharmaceutical preparations for use in gastroenterology, ophthalmology, ocular disorders; pharmaceutical preparations, namely, allergy medication, antacids, antibiotics, anticonvulsants, diarrhea medication, gastro-intestinal pharmaceuticals, sedativesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 15, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 15, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 20, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 2, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 2, 2023INPCINVALIDATION PROCESSED—
Jul 4, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 4, 2022C71TCANCELLED SECTION 71—
Apr 19, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 31, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 12, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 9, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 12, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 20, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 20, 2016FIMPFINAL DISPOSITION PROCESSED—
Jul 19, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 19, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 2, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 2, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 31, 2016GPNXNOTIFICATION PROCESSED BY IB—
Jan 13, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 13, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 13, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 30, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 21, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 24, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 24, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 24, 2015CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 16, 2015ALIEASSIGNED TO LIE—
Oct 28, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 27, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 27, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 26, 2015DOCKASSIGNED TO EXAMINER—
May 16, 2015RFNTREFUSAL PROCESSED BY IB—
Apr 30, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 30, 2015RFRRREFUSAL PROCESSED BY MPU—
Apr 29, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 28, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2015DOCKASSIGNED TO EXAMINER—
Mar 14, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 10, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 5, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance